Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Albireo Pharma Inc (ALBO)

Albireo Pharma Inc (ALBO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Albireo Pharma Inc 10 POST OFFICE SQUARE SUITE 1000 SOUTH BOSTON MA 02109 USA

P: 857-254-5555

Description:

Albireo Pharma, Inc. is a biopharmaceutical company. It focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo Pharma Inc., formerly known as BIODEL INC., is based in Boston, United States.

Key Statistics

Overview:

Market Capitalization, $K 485,638
Shares Outstanding, K 19,279
Annual Sales, $ 8,310 K
Annual Net Income, $ -107,630 K
Last Quarter Sales, $ 3,660 K
Last Quarter Net Income, $ 57,090 K
60-Month Beta 1.46
% of Insider Shareholders 5.00%
% of Institutional Shareholders 80.74%
Float, K 18,315
% Float 95.00%

Growth:

1-Year Return -35.64%
3-Year Return -10.09%
5-Year Return -6.56%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 54.28%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -6.75
EPS Growth vs. Prev Qtr 33.68%
EPS Growth vs. Prev Year 35.71%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 11/04/16

ALBO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -9.62
Price/Earnings to Growth N/A
Return-on-Equity % -82.99%
Return-on-Assets % -49.29%
Profit Margin % -1,295.19
Net Margin % N/A
Debt/Equity 0.07
Price/Sales 58.15
Price/Cash Flow N/A
Price/Book 2.67
Book Value/Share 9.43
Interest Coverage -8.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar